Your session is about to expire
← Back to Search
Physician Payment Models for Heart Conditions
Phase 3
Waitlist Available
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient inclusion: discharge diagnosis of heart failure or myocardial infarction.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Summary
This trial will compare two models for physician payment, one in which physicians are paid a fee for each service provided (fee-for-service), and one in which physicians are given a bonus for meeting quality standards (pay-for-performance). The goal is to see if the pay-for-performance model results in better care for patients with heart conditions.
Who is the study for?
This trial is for patients with a discharge diagnosis of heart failure or myocardial infarction. It also includes resident physicians at the University of Virginia who work in Acute Cardiology, Coronary Care Unit, or General Medicine Service and are not part of the study team.Check my eligibility
What is being tested?
The study aims to compare two payment models for doctors: 'pay for performance' versus traditional 'fee for service'. The focus is on whether financial incentives can improve adherence to healthcare standards in treating heart conditions.See study design
What are the potential side effects?
Since this trial involves financial compensation methods rather than medical treatments, there are no direct medical side effects. However, changes in physician behavior could indirectly affect patient care outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I was diagnosed with heart failure or had a heart attack.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
compliance with composite pay for performance measure
Secondary outcome measures
heart failure composite score
myocardial infarction score
readmission rate
Trial Design
2Treatment groups
Active Control
Group I: pay for performanceActive Control1 Intervention
Group II: no pay for performanceActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
761 Previous Clinical Trials
1,256,000 Total Patients Enrolled
11 Trials studying Heart Failure
1,527 Patients Enrolled for Heart Failure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was diagnosed with heart failure or had a heart attack.
Research Study Groups:
This trial has the following groups:- Group 1: pay for performance
- Group 2: no pay for performance
Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger